TXG logo

TXG
10x Genomics Inc - Ordinary Shares - Class A

2,790
Mkt Cap
$2.89B
Volume
2.42M
52W High
$26.45
52W Low
$7.72
PE Ratio
-64.16
TXG Fundamentals
Price
$22.43
Prev Close
$22.05
Open
$22.05
50D MA
$21.32
Beta
1.96
Avg. Volume
2.51M
EPS (Annual)
-$0.3491
P/B
3.60
Rev/Employee
$545,690.15
$1,595.62
Loading...
Loading...
News
all
press releases
M&T Bank Corp Has $1.19 Million Stake in 10x Genomics $TXG
M&T Bank Corp boosted its stake in 10x Genomics (NASDAQ:TXG - Free Report) by 258.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,188 shares of the company's stock after purchasing an additional 52,771 shares du...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday
10x Genomics (NASDAQ:TXG) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat·3d ago
News Placeholder
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference 10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference PR Newswire PLEASANTON, Calif., April 29...
PR Newswire·3d ago
News Placeholder
10x Genomics (NASDAQ:TXG) Trading Down 8% - What's Next?
10x Genomics (NASDAQ:TXG) Stock Price Down 8% - Time to Sell...
MarketBeat·3d ago
News Placeholder
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms PR Newswire VANCOUVER, BC, April 29, 2026...
PR Newswire·4d ago
News Placeholder
10x Genomics (NASDAQ:TXG) Stock Price Up 5.9% - Here's What Happened
10x Genomics (NASDAQ:TXG) Stock Price Up 5.9% - What's Next...
MarketBeat·5d ago
News Placeholder
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
TEM faces pressure ahead of Q1 earnings as macro headwinds, high valuation and estimate trends cloud its near-term investment appeal.
Zacks·6d ago
News Placeholder
10x Genomics $TXG Shares Acquired by Caprock Group LLC
Caprock Group LLC raised its holdings in shares of 10x Genomics (NASDAQ:TXG - Free Report) by 59.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·9d ago
News Placeholder
Labcorp Gears Up to Report Q1 Earnings: What's in Store?
LH heads into Q1 earnings results with rising diagnostics demand, new partnerships, and AI-driven tools boosting growth across testing and consumer health.
Zacks·12d ago
<
1
2
...
>

Latest TXG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.